Presentation Intravascular Coronary Imaging and Physiology 2018 PCI should not be first line therapy for patients with stable CAD – Lessons learned from ORBITA Presenter: Rasha Al-Lamee May 05, 2018 REGISTER for free or LOG IN to view this content Coronary CAD Pharma Presentation Intravascular Coronary Imaging and Physiology 2018 PCI Up Next Presentation Intravascular Coronary Imaging and Physiology 2018 ORBITA Trial Presenter: Paul S. Teirstein May 05, 2018 More slides + Presentation Intravascular Coronary Imaging and Physiology 2018 Show me the Data: Evidence that Physiologic Lesion Assessment Improves Patient Outcomes (or provides clinical value) Presenter: Morton J. Kern May 05, 2018 Presentation Intravascular Coronary Imaging and Physiology 2018 The ILUMIEN Series of Trials Presenter: Ziad A. Ali May 05, 2018 We Recommend
Presentation Intravascular Coronary Imaging and Physiology 2018 ORBITA Trial Presenter: Paul S. Teirstein May 05, 2018
Presentation Intravascular Coronary Imaging and Physiology 2018 Show me the Data: Evidence that Physiologic Lesion Assessment Improves Patient Outcomes (or provides clinical value) Presenter: Morton J. Kern May 05, 2018
Presentation Intravascular Coronary Imaging and Physiology 2018 The ILUMIEN Series of Trials Presenter: Ziad A. Ali May 05, 2018